Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies
Status unconfirmed · Not applicable
Conditions studied: Cancer, Ovarian, Chemotherapy Effect, Calorie Deficiency, Fasting, Intermittent
In brief
This study evaluates how lifestyle modifications that may be made to manage chemotherapy side effects in patients with gynecologic malignancies.
Key facts
- Study ID
- NCT06376604
- Run by
- L-Nutra Inc
- People needed
- 30
- Starts
- 2021-09-08
- Expected to finish
- 2025-12-30
- Last updated by the study team
- 2024-04-19
Who can join
Age: 35 and older, up to 70. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Women
- Age 35-70 years old (both inclusive)
- Biopsy proven gynecologic malignancy
- Scheduled to or currently undergoing chemotherapy, with a minimum of 6 cycles remaining
- BMI greater than or equal to 18.5
- Adequate renal function (serum creatinine less than 1.5 times the upper limit of normal)
- Willing to adhere to a 5-day fasting mimicking diet
You may not qualify if…
- Pregnant or nursing mothers
- Prisoners
- Patients with diabetes or history of hypoglycemia
- Taking daily medications that cannot be safely taken without food
- History of significant or unstable cardiac disease such as congestive heart failure or history of myocardial infarction, stroke or pulmonary embolism within the last 3 months, renal failure, history of - eating disorder, dementia, psychosis, impaired physical mobility.
- Significant medical comorbidity that would be dangerous with a fasting mimicking diet.
- Any known or suspected food allergies that overlap with the FMD/Transitional diet by L-Nutra meal kit ingredients.
Where it is running
- The University of Tennessee Medical Center — Knoxville, Tennessee, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.